Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils

Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. G. Lyubimov, G. Y. Lyubimov, V. A. Kozlov
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:820d9422bfb04e079b7c77e941d3681f
record_format dspace
spelling oai:doaj.org-article:820d9422bfb04e079b7c77e941d3681f2021-11-23T06:14:36ZFormation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils2541-94202587-959610.12737/23403https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f2016-09-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/289https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and only then inject these "loaded" zymosan neutrophils into the bloodstream. Our experiments showed a total inhibition of the weight accretion of both tumor affected liver (from 5220 ± 963 to 1327 ± 219 mg) and spleen (from 328 ± 29 to 187 ± 64 mg) of mice. Thus these data showed that even on the 17th day after a single intravenous injection zymosan-treated neutrophils persist expressed manifestations of anti-tumor activity in the liver and spleen, that may be basis for using this method for antimetastatic preventive measures in liver and other localizations.A. G. LyubimovG. Y. LyubimovV. A. KozlovScientific Сentre for Family Health and Human Reproduction Problemsarticlemelanomaneutrophilszymosanglucanliver tumorsspleenScienceQRUActa Biomedica Scientifica, Vol 1, Iss 5, Pp 110-113 (2016)
institution DOAJ
collection DOAJ
language RU
topic melanoma
neutrophils
zymosan
glucan
liver tumors
spleen
Science
Q
spellingShingle melanoma
neutrophils
zymosan
glucan
liver tumors
spleen
Science
Q
A. G. Lyubimov
G. Y. Lyubimov
V. A. Kozlov
Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
description Application of zymosan in medicine is limited because of its side effects, since the native granules of zymosan directly activate serum complement components and phagocytic cells. In this regard, it was decided at the outset (ex vivo) to incorporate the granules of zymosan in the neutrophils, and only then inject these "loaded" zymosan neutrophils into the bloodstream. Our experiments showed a total inhibition of the weight accretion of both tumor affected liver (from 5220 ± 963 to 1327 ± 219 mg) and spleen (from 328 ± 29 to 187 ± 64 mg) of mice. Thus these data showed that even on the 17th day after a single intravenous injection zymosan-treated neutrophils persist expressed manifestations of anti-tumor activity in the liver and spleen, that may be basis for using this method for antimetastatic preventive measures in liver and other localizations.
format article
author A. G. Lyubimov
G. Y. Lyubimov
V. A. Kozlov
author_facet A. G. Lyubimov
G. Y. Lyubimov
V. A. Kozlov
author_sort A. G. Lyubimov
title Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
title_short Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
title_full Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
title_fullStr Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
title_full_unstemmed Formation of sustained antitumor effect in mice’s liver and spleen (CBA х C57BL/6)F1 after a single intravenous injection of zymosan-treated neutrophils
title_sort formation of sustained antitumor effect in mice’s liver and spleen (cba х c57bl/6)f1 after a single intravenous injection of zymosan-treated neutrophils
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2016
url https://doaj.org/article/820d9422bfb04e079b7c77e941d3681f
work_keys_str_mv AT aglyubimov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils
AT gylyubimov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils
AT vakozlov formationofsustainedantitumoreffectinmicesliverandspleencbahc57bl6f1afterasingleintravenousinjectionofzymosantreatedneutrophils
_version_ 1718417018359644160